Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (148)

2024

  1. Correction to: Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial (Nature Communications, (2024), 15, 1, (5251), 10.1038/s41467-024-49121-3)

    Nature Communications

  2. Correction to: dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe (Nature Communications, (2024), 15, 1, (3736), 10.1038/s41467-024-47751-1)

    Nature Communications

  3. dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe

    Nature Communications, Vol. 15, Núm. 1

2023

  1. Association between periodontitis and peripheral markers of innate immunity activation and inflammation

    Journal of Periodontology, Vol. 94, Núm. 1, pp. 11-19

  2. Influence of Temperature Chronobiology on Stroke Outcome

    International Journal of Molecular Sciences, Vol. 24, Núm. 4

2022

  1. A Polygenic Risk Score Based on a Cardioembolic Stroke Multitrait Analysis Improves a Clinical Prediction Model for This Stroke Subtype

    Frontiers in Cardiovascular Medicine, Vol. 9

  2. Antihyperthermic Treatment in the Management of Malignant Infarction of the Middle Cerebral Artery

    Journal of Clinical Medicine, Vol. 11, Núm. 10

  3. Endothelial NO synthase 786T/T polymorphism increases hemorrhagic transformation after endovascular thrombectomy

    Nitric Oxide - Biology and Chemistry, Vol. 129, pp. 8-15

  4. Neurological Instability in Ischemic Stroke: Relation with Outcome, Latency Time, and Molecular Markers

    Translational Stroke Research, Vol. 13, Núm. 2, pp. 228-237

  5. Surrogate biomarkers of outcome for wake-up ischemic stroke

    BMC Neurology, Vol. 22, Núm. 1

  6. The Smoking Paradox in Stroke Patients Under Reperfusion Treatment Is Associated With Endothelial Dysfunction

    Frontiers in Neurology, Vol. 13

  7. sTWEAK is a leukoaraiosis biomarker associated with neurovascular angiopathy

    Annals of Clinical and Translational Neurology, Vol. 9, Núm. 2, pp. 171-180

2021

  1. Article targeting pro-oxidant iron with deferoxamine as a treatment for ischemic stroke: Safety and optimal dose selection in a randomized clinical trial

    Antioxidants, Vol. 10, Núm. 8

  2. Characterization of a temporal profile of biomarkers as an index for ischemic stroke onset definition

    Journal of Clinical Medicine, Vol. 10, Núm. 14

  3. Mild systemic inflammation enhances response to OnabotulinumtoxinA in chronic migraineurs

    Scientific Reports, Vol. 11, Núm. 1

  4. Network protein interaction in the link between stroke and periodontitis interplay: A pilot bioinformatic analysis

    Genes, Vol. 12, Núm. 5

  5. Obesity-related genetic determinants of stroke

    Brain Communications, Vol. 3, Núm. 2

  6. Random forest-based prediction of stroke outcome

    Scientific Reports, Vol. 11, Núm. 1

  7. Rp11-362k2.2:Rp11-767i20.1 genetic variation is associated with post-reperfusion therapy parenchymal hematoma. a gwas meta-analysis

    Journal of Clinical Medicine, Vol. 10, Núm. 14

  8. STWEAK is a marker of early haematoma growth and leukoaraiosis in intracerebral haemorrhage

    Stroke and Vascular Neurology, Vol. 6, Núm. 4, pp. 528-535